FOXO6 promotes gastric cancer cell tumorigenicity via upregulation of C-myc

被引:35
作者
Li Qinyu [1 ,2 ]
Cui Long [1 ,2 ]
Du Zhen-dong [3 ]
Shi Min-min [1 ]
Wu Wei-ze [1 ,2 ]
Yang Wei-ping [1 ,2 ]
Peng Cheng-hong [1 ,2 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Digest Surg, Shanghai 200030, Peoples R China
[2] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Surg, Shanghai 200030, Peoples R China
[3] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Clin Lab, Shanghai 200030, Peoples R China
关键词
Gastric cancer; Cell proliferation; FOXO6; C-myc; HNF4; FORKHEAD TRANSCRIPTION FACTORS; HUMAN HEPATOCELLULAR-CARCINOMA; TUMOR-SUPPRESSOR; PROTEIN-KINASE; LIVER; GENE; DIFFERENTIATION; MICE; RAS;
D O I
10.1016/j.febslet.2013.05.027
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The aberrant regulation of many related genes is involved in the development and progression of gastric carcinoma. In the present study, we show that mRNA and protein levels of FOXO6 are upregulated in gastric cancer tissues. Forced overexpression of FOXO6 promotes gastric cancer cell proliferation, while knockdown of FOXO6 expression inhibits proliferation. We show that ectopic FOXO6 expression induces the expression of C-myc. Furthermore, we found that FOXO6 physically interacts with the transcription factor hepatic nuclear factor 4 (HNF4) in gastric cancer cells. FOXO6 induces C-myc expression by associating to HNF4 and mediating histone acetylation, and the dissociation of HDAC3 from the promoter of the C-myc gene. Therefore, our results suggest a previously unknown FOXO6/HNF4/C-myc molecular network controlling gastric cancer development. Structured summary of protein interactions: FOXO6 physically interacts with HNF4 by anti bait coimmunoprecipitation (View Interaction: 1, 2) (C) 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:2105 / 2111
页数:7
相关论文
共 33 条
  • [1] Almhanna K, 2011, ANTICANCER RES, V31, P4387
  • [2] New targeted therapies for gastric cancer
    Asaoka, Yoshinari
    Ikenoue, Tsuneo
    Koike, Kazuhiko
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2011, 20 (05) : 595 - 604
  • [3] Cairo Stefano, 2012, Front Biosci (Elite Ed), V4, P480
  • [4] MAX and MYC: A Heritable Breakup
    Cascon, Alberto
    Robledo, Mercedes
    [J]. CANCER RESEARCH, 2012, 72 (13) : 3119 - 3124
  • [5] Current questions for the treatment of advanced gastric cancer
    Cervantes, A.
    Roda, D.
    Tarazona, N.
    Rosello, S.
    Perez-Fidalgo, J. A.
    [J]. CANCER TREATMENT REVIEWS, 2013, 39 (01) : 60 - 67
  • [6] MYC on the Path to Cancer
    Dang, Chi V.
    [J]. CELL, 2012, 149 (01) : 22 - 35
  • [7] Hepatocyte Nuclear Factor-4α Promotes Gut Neoplasia in Mice and Protects against the Production of Reactive Oxygen Species
    Darsigny, Mathieu
    Babeu, Jean-Philippe
    Seidman, Ernest G.
    Gendron, Fernand-Pierre
    Levy, Emile
    Carrier, Julie
    Perreault, Nathalie
    Boudreau, Francois
    [J]. CANCER RESEARCH, 2010, 70 (22) : 9423 - 9433
  • [8] FOXO transcription factors at the interface between longevity and tumor suppression
    Greer, EL
    Brunet, A
    [J]. ONCOGENE, 2005, 24 (50) : 7410 - 7425
  • [9] H3 Lysine 4 Is Acetylated at Active Gene Promoters and Is Regulated by H3 Lysine 4 Methylation
    Guillemette, Benoit
    Drogaris, Paul
    Lin, Hsiu-Hsu Sophia
    Armstrong, Harry
    Hiragami-Hamada, Kyoko
    Imhof, Axel
    Bonneil, Eric
    Thibault, Pierre
    Verreault, Alain
    Festenstein, Richard J.
    [J]. PLOS GENETICS, 2011, 7 (03):
  • [10] HNF-4α:: from MODY to late-onset type 2 diabetes
    Gupta, RK
    Kaestner, KH
    [J]. TRENDS IN MOLECULAR MEDICINE, 2004, 10 (11) : 521 - 524